Therapeutics

Physician pioneers technique offering higher perspective in surgery, outcomes.

With intraoperative sustained release steroids, ophthalmologists can eliminate the gambles of patient adherence.

Study supports preoperative ocular surface optimization with artificial tears.

Change can prove to benefit individuals with diabetes, other comorbidities.

Procedure increases lens stability and improves visual acuity in patients.

Robert Ang, MD, discusses highlights of his AAO 2020 presentation on a study analyzing the vIsual outcomes of a small-aperture IOL implantation in patients with a history of post-laser refractive surgery.

Advances in laser-vision correction provide visual results that often surpass 20/20.

Speaking during the American Academy of Ophthalmology’s virtual 2020 annual meeting, Neal H. Shorstein, MD, explained how physicians at Kaiser Permanente have been using a prophylactic drop-free drug regimen before cataract surgery for more than a decade. Their regimen is so streamlined that the only drop that patients receive in anticipation of cataract surgery is a supplemental dilation drop instilled preoperatively while they are still in the holding area.

Elevated pressure can lead to irreversible optic nerve damage, vision loss

Optics block out-of-focus and stray light, allow continuum of vision.

Sustained release helps mitigate disease progression without impacting quality of life.

Large randomized trial compares efficacy and safety of multiple regimens

Study points to possible role of addressing preprocedural anxiety

Surveyed patients express dissatisfaction with efficacy of eye drops.

A number of options may offer major cost savings, positive results for patients.

RLE, in unexpected twist, is gaining support among surgeons

Options can reduce the treatment burden for patients, leading to improved outcomes

Investigators find value in screening for macular disease in preoperative evaluation

Following cataract surgery, the dropless option is proving to be a preferred method during recovery

ICYMI: Alice Epitropoulos, MD, FACS, speaks on "Image quality or depth of field or both: Clinical outcomes from spherical aberration neutral monofocal toric IOL," during the 2020 ASCRS virtual meeting.

As more novel ophthalmic drugs and devices become available under the CMS “pass-through”designation, practices should be proactive in embracing these products.

Bonuses are the norm and not risked by pass-through medication use

According to William D. Trattler, MD, surgeons today can choose from a number of newer modalities that address the drawbacks associated with previous options.